AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Caspofungin Acetate Equivalent To Caspofungin

12 registrations across 1 African market— 5 active

Markets with Caspofungin Acetate Equivalent To Caspofungin

🇿🇦South Africa
12 registrations
5 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
CASPOFUNGIN 70🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveJun 2029
CASPOLYN 50🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveJun 2029
CASPOFUNGIN 50 mg ADCO🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveSept 2027
CASPOFUNGIN 70 mg ADCO🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveSept 2027
MSD-CASPOFUNGIN 50 mg🇿🇦South AfricaMSD (Pty) LtdsuspendedMay 2025
MSD-CASPOFUNGIN 70 mg🇿🇦South AfricaMSD (Pty) LtdsuspendedMay 2025
CIRION 50🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedNov 2024
CIRION 70🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedNov 2024
CASPOFUNGIN 50 CIPLA🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedNov 2024
CASPOFUNGIN 70 CIPLA🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedNov 2024
CANCIDAS 70 mg INJECTION🇿🇦South AfricaMSD (Pty) LtdsuspendedOct 2024
CANCIDAS 50 mg INJECTION🇿🇦South AfricaMSD (Pty) LtdactiveJan 1900

Caspofungin Acetate Equivalent To Caspofungin in Africa — Regulatory Overview

Caspofungin Acetate Equivalent To Caspofungin is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 5 (42%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.